IL-10 and TNF-α polymorphisms and the recovery from HCV infection

Human Immunology

Volumn 64, Issue 7, 2003, Pages 674-680

  Lio, Domenico ^a   Caruso, Calogero ^a,b   Di Stefano, Rosa ^a   Colonna Romano, Giuseppina ^a   Ferraro, Donatella ^a   Scola, Letizia ^a   Crivello, Antonio ^a   Licata, Anna ^a   Valenza, L Mario ^a   Candore, Giuseppina ^a   Craxì, Antonio ^a   Almasio, Piero L ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Laboratorio di Immunopatologia   (Italy)

Author keywords

Cytokine; HCV; IL 10; Polymorphisms; TNF

Indexed keywords

INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS C; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 10744230051     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(03)00080-6     Document Type: Article

References (50)

1. Hill AVS: The immunogenetics of human infectious diseases. Annu Rev Immunol 16:593, 1998.
2. Boyartchuk V, Dietrich W: Genetic dissection of host immune response. Genes Immunity 3:119, 2002.
3. Hoofnagle J: Hepatitis C: the clinical spectrum of disease. Hepatology 26:15S, 1997.
4. Koziel MJ: The role of immune responses in the pathogenesis of hepatitis C virus infection. J Viral Hepat 4:31, 1997.
5. Lechmann M, Schneider EM, Giers G, Kaiser R, Dumoulin FL, Sauerbruch T, Spengler U: Increased frequency of the HLA-DR15 (B1*15011) allele in German patients with self limited hepatitis C virus infection. Eur J Clin Invest 29:337, 1999.
6. Thursz M, Yallop R, Goldin R, Trepo C, Thomas HC: Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research. Lancet 354:2119, 1999.
7. Thio CL, Thomas DL, Carrington M: Chronic viral hepatitis and the human genome. Hepatology 31:819, 2000.
8. Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF, Oksenberg J, McNicholl J, Pociot F, Hardt C, D'Alfonso S: Cytokine gene polymorphism in human disease: on-line databases, supplement 1. Genes Immunol 2:61, 2001.
9. Tilg H, Diehl AM: Cytokines in alcohlic and nonalcoholic steatohepatitis. N Engl J Med 343:1467, 2000.
10. Nelson DR, Lim HL, Marousis CG, Fang JW, Davis GL, Shen L, Urdea MS, Kolberg JA, Lau JY: Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection. Dig Dis Sci 42:2487, 1997.
11. Hohler T, Kruger A, Gerken G, Schneider PM, Meyer zum Buschenfelde KH, Rittner CI: Tumor necrosis factor alpha promoter polymorphism at position -238 is associated with chronic active hepatitis C infection. J Med Virol 54:173, 1998.
12. Edwards-Smith C, Jonsson J, Purdie D, Bansal A, Shorthouse C, Powell E: Interleukin 10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon-alpha. Hepatology 30:526, 1999.
13. Powell EE, Edwards-Smith CJ, Hay JL, Clouston AD, Crawford DH, Shorthouse C, Purdie DM, Jonsson JR: Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 31:828, 2000.
14. Yee LJ, Tang J, Gibson AW, Kimberly R, van Leeuwen DJ, Kaslow RA: Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology 33:708, 2001.
15. Rosen HR, McHutchison JG, Conrad AJ, Lentz JJ, Marousek G, Rose SL, Zaman A, Taylor K, Chou S: Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C. Am J Gastroentero 97:714, 2002.
16. Vidigal PG, Germer JJ, Zein NN: Polymorphisms in the interleukin-10, tumor necrosis factor-α, and transforming growth factor-β1 genes in chronic hepatitis C patients treated with interferon and ribavirin. J Hepatology 36:271, 2002.
17. Yee LJ, Tang J, Herrera J, Kaslow RA, van Leeuwen DJ: Tumor necrosis factor gene polymorphisms in patients with chirrosis from chronic hepatitis C virus infection. Genes Immunity 1:386, 2000.
18. Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok CC, French M, Mallal S, Christiansen F: The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 167:257, 1999.
19. Candore G, Lio D, Colonna Romano G, Caruso C: Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions. Autoimmunity Rev 1:29, 2002.
20. Lio D, Candore G, Colombo A, Colonna Romano G, Gervasi F, Marino V, Scola L, Caruso C: A genetically determined high setting of TNF-α influences immunological parameters of HLA-B8, DR3 positive subjects: implications for autoimmunity. Hum Immunol 62:705, 2001.
21. Skoog T, van't Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, Eriksson P, Hamsten A: A common functional polymorphism (C → A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 8:1443, 1999.
22. Kube D, Rieth H, Eskdale J, Kremsner PG, Gallagher G: Structural characterisation of the distal 5′ flanking region of the human interleukin-10 gene. Genes Immunity 2:181, 2001.
23. Koch W, Kastrati A, Bottiger C, Mehilli J, von Beckerath N, Schomig A: Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 159:137, 2001.
24. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV: An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24:1, 1997.
25. Lio D, Scola L, Crivello A, Colonna Romano G, Candore G, Bonafè M, Cavallone L, Franceschi C, Caruso C: Gender specific association between -1082 IL-10 promoter polymorphism and longevity. Genes Immunity 3:30, 2002.
26. Cataldo F, Lio D, Marino V, Scola L, Crivello A, Mulè AM, Corazza GR: Cytokine genotyping (TNF and IL-10) in patients with celiac disease and selective IgA deficiency. Am J Gastroenterol 98:850, 2003.
27. Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Bonafè M, Cavallone L, Marchigiani F, Oliveri F, Franceschi C, Caruso C: Inflammation, genetics and longevity: further studies on the protective effects in men of IL-10-1082 promoter SNP and its interaction with -308 TNF-α promoter SNP. J Med Genetics 40:296, 2003.
28. Lio D, Licastro F, Scola L, Chiappelli M, Grimaldi LM, Crivello A, Colonna-Romano G, Candore G, Franceschi C, Caruso C: Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease. Genes Immun 4:234, 2003.
29. Eskdale J, Keijsers V, Huizinga T, Gallagher G: Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immunity 1:151, 1999.
30. Makhatadze NJ: Tumor necrosis factor locus: genetic organisation and biological implications. Hum Immunol 59:571, 1998.
31. Opal SM, Huber CE: The role of interleukin-10 in critical illness. Curr Opinion Infect Dis 13:221, 2001.
32. Shata MT, Anthony DD, Carlson NL, Andrus L, Brotman B, Tricoche N, McCormack P, Prince A: Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees. J Viral Hepat 9:400, 2002.
33. Cribier B, Schmitt C, Rey D, Lang JM, Kirn A, Stoll-Keller F: Production of cytokines in patients infected by hepatitis C virus. J Med Virol 55:89, 1998.
34. Macias J, Sanchez-Quijano A, Pineda JA, Abad MA, Rubio A, Rosa R, Leal M, Lissen E: Minimal liver injury in chronic hepatitis C virus infection is associated with low levels of soluble TNF-alpha/Fas receptors and acquisition in childhood. Liver 21:410, 2001.
35. Ando K, Hiroishi K, Kaneko T, Moriyama T, Muto Y, Kayagaki N, Yagita H, Okumura K, Imawari M: Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J Immunol 158:5283, 1997.
36. Hajeer AH, Hutchinson IV: Influence of TNFα gene polymorphisms on TNFα production and disease. Hum Immunol 62:1191, 2001.
37. Udalova IA, Richardson A, Denys A, Smith C, Ackerman H, Foxwell B, Kwiatkowski D: Functional consequences of polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region. Mol Cell Biol 20:9113, 2000.
38. Foey AD, Parry SL, Williams LM, Feldmann M, Foxwell BM, Brennan FM: Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinases. J Immunol 160:920, 1998.
39. Piazzolla G, Tortorella C, Schiraldi O, Antonaci S: Relationship between interferon-gamma, interleukin-10, and interleukin-12 production in chronic hepatitis C and in vitro effects of interferon-alpha. J Clin Immunol 20:54, 2000.
40. Nelson DR, Lim HL, Marousis CG, Fang JW, Davis GL, Shen L, Urdea MS, Kolberg JA, Lau JY: Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection. Dig Dis Sci 42:2487, 1997.
41. Napoli J, Bishop GA, McGuinnes PH, Painter DM, McCaughan GW: Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of th1-associated cytokines. Hepatology 26:471, 1996.
42. Baroni GS, Pastorelli A, Manzin A, Benedetti A, Marucci L, Solforosi L, Di Sario A, Brunelli E, Orlandi F, Clementi M, Macarri G: Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C. Liver 19:212, 1999.
43. Nelson DR, Lauwers GY, Lau JY, Davis GL: Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. Gastroenterology 118:655, 2000.
44. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P.: Host genetic factors influence disease progression in chronic hepatitis C. Arthritis Rheum 42:1101, 1999.
45. Reynard MP, Turner D, Navarrete CV: Allele frequencies of polymorphisms of the tumour necrosis factor-α, interleukin-10, interferon-γ and interleukin-2 genes in a North European Caucasoid group from the UK. Eur J Immunogenet 27:241, 2000.
46. Cox ED, Hoffmann SC, DiMercurio BS, Wesley RA, Harlan DM, Kirk AD, Blair PJ: Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. Transplantation 72:720, 2001.
47. Poli F, Nocco A, Berra S, Scalamogna M, Taioli E, Longhi E, Sirchia G: Allele frequencies of polymorphisms of TNFA, IL-6, IL-10 and IFNG in an Italian Caucasian population. Eur J Immunogenet 29:237, 2002.
48. McKiernan S, Daly J, Curry MP: Polymorphisms of the TNF-α gene promoter region in hepatitis C infection. Hepatology 30:360A, 1999 (Abstract).
49. Perneger TV: What's wrong with Bonferroni adjustments? Br Med J 316:1236, 1998.
50. Lio D, Marino V, Gioia V, Serauto A, Scola L, Crivello A, Forte GI, Colonna-Romano G, Candore G, Caruso C: Genotypic frequencies of +874T 224 A single nucleotide polymorphism at the first intron of interferon-γ gene in a sample of Sicilian patients affected by tuberculosis. Eur J Immunogenet 29:371, 2002.